Food and Drug Administration
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
See attached Notice of Intent to Sole Source requirement for Sprague Dawley rats for protocols: E07877.01 and E07876.01 to access the toxicity of tobacco derived nicotine after repeated inhalation. Both studies will provide robust scientific data | Type: Special Notice | Sol#: FDA-130321
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
See attached Special Notice: Intent to award open market items over $25k with GSA order for purchase of a Rapid Evaporative Ionization Mass Spectrometry (REIMS) source and Ultra High Pressure Liquid Chromatography (UHPLC) System | Type: Special Notice
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
The U.S. Food and Drug Administration (FDA) intends to solicit a 12-month base year, plus three (3) four-month option periods, sole source, time-and-materials type contract from Acumen LLC; 500 Airport Blvd., Suite 100; Burlingame, CA 94010, in ac | Type: Special Notice | Sol#: NOI_SS_CBER-2025-1269
Food and Drug Administration
Food and Drug Administration
Food and Drug Administration
Food and Drug Administration
Food and Drug Administration
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION
See attached sole source Notice | Type: Special Notice | Sol#: 7-25-2025
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
Notice of Intent to Sole Source Subject: Sole Source Fixed Price Contract for the procurement of Preventative Maintenance & Repair Services for Bruker Avance III under Request for Quote FDA-RFQ-25Q1285494 Notic | Type: Special Notice | Sol#: RFQ25Q1285494
Food and Drug Administration
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
Pursuant to the authority of 41 USC 3304(a)(1), as implemented by Federal Acquisition Regulation (FAR) Subpart 6.302-1, the U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grant Services (OAGS) intends to award a sole source co | Type: Special Notice | Sol#: 75F40125Q00205
Food and Drug Administration
Food and Drug Administration
Food and Drug Administration
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
Center for Devices and Radiological Health (CDRH) requires contractor assistance to continue to support CDRH’s strategic vision for the Compliance and Quality program, and Quality and Compliance Training. The primary objective of thi | Type: Special Notice | Sol#: FDA-CDRH-2025-126555
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
AMENDMENT #4 (8/15/2025) : Due date for responses extended until 12:00pm (Eastern) on Wednesday, August 20, 2025. Additional responses to frequently asked questions have been attached. AMENDMENT #3 (8/13/2025)< | Type: Special Notice | Sol#: 75F40125RFI00099
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
FDA is seeking 4 different human cell types and specific reagents to successfully thaw cryopreserved cells and maintain them in in-vitro cell culture to support evaluation of drug safety, metabolism, and efficacy to support mission-critic | Type: Special Notice | Sol#: FDA-CDER-25-128749
Food and Drug Administration
Food and Drug Administration
Food and Drug Administration
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
The contractor shall provide on-site recertification and annual preventative maintenance, calibration, and prompt repair(s) if needed as well as a certification report after each PM and/or repair. Service shall be provided by an engineer from Orig | Type: Special Notice | Sol#: FDA_75F40125Q00360
Food and Drug Administration
Food and Drug Administration
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION
The U.S. Food and Drug Administration (FDA) intends to award, on a sole source basis, a contract modification to increase the ceiling of the current Indefinite Delivery/Indefinite Quantity (IDIQ) bridge contract (Contract No. 75F4 | Type: Special Notice | Sol#: OC-2025-131060
Food and Drug Administration
Food and Drug Administration
Food and Drug Administration
Food and Drug Administration
Food and Drug Administration
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
People infected with SARS-CoV-2 (the virus that causes COVID-19) typically recover within a few days or weeks. However some individuals have long-term effects that persist for multiple weeks, months, or even years; this is known as post-COVID | Type: Special Notice | Sol#: FDA-OC-25-130611
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
The Division of Applied Regulatory Science (DARS) OCP/OTS/CDER operates 6 total labs that provides mission-critical research supporting review questions, translational science, and emerging public health issues for CDER and FDA. We develop and eva | Type: Special Notice | Sol#: FDA-CDER-25-130459
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF OPERATIONS
Notice of Justification for Exemption from Fair Opportunity THIS ANNOUCMENT IS NOT A REQUEST FOR PROPOSAL The US Food and Drug Administration {FDA), Office of Finance Budget Acquisition and | Type: Special Notice | Sol#: 75F40125R00116
Food and Drug Administration
Food and Drug Administration
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
The immunology laboratory requires a range of routine supplies to maintain operational readiness and conduct scientific experiments to support regulatory research. We perform a range of assays to answer scientific questions associated with the rev | Type: Special Notice | Sol#: FDA-CDER-25-130466
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF OPERATIONS
Notice of Intent Sole Source THIS ANNOUNCEMENT IS NOT A REQUEST FOR PROPOSAL The US Food and Drug Administration {FDA), Office of Finance Budget Acquisition and Planning, intends to issue a single sole-source award | Type: Special Notice | Sol#: 75F40125R00117
Food and Drug Administration
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF OPERATIONS
Notice of Intent Sole Source THIS ANNOUNCEMENT IS NOT A REQUEST FOR PROPOSAL The US Food and Drug Administration {FDA), Office of Finance Budget Acquisition and Planning, intends to issue a single sole-source award | Type: Special Notice | Sol#: 75F40125R00118
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
The U.S. Food and Drug Administration (FDA) New York Human and Animal Food Laboratory (NYHAFL) conducts sample analysis on human and animal foods. The BSL3 laboratory requires a fully functional autoclave to decontaminate all waste and any other m | Type: Special Notice | Sol#: HFP-2025-129650
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION
NOTICE OF INTENT TO SOLE SOURCE In support of Project No: CDER-OTS-25-C-1691 The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services, Facilities Support Branch inten | Type: Special Notice
Food and Drug Administration
Food and Drug Administration
Food and Drug Administration
Food and Drug Administration
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
Notice of Intent to Sole Source - Quality and Compliance Training Support The Food and Drug Administration (FDA) intends to award a sole source, firm fixed price type contract to Association for t | Type: Special Notice | Sol#: FDA-CDRH-2025-126555-1
Food and Drug Administration
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA CENTER FOR DRUG EVALUATION AND RESEARCH
Justification for Other than Full and Open Competition. See Attachment. | Type: Special Notice | Sol#: FDAJOFOC8292025
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA Office of Acquisitions and Grants Services
Amendment 05 - The BAA Notice has been updated to version 6 with various changes throughout. Amendment 04 - The BAA Notice has been updated to version 5 with various changes throughout. Table 1 and attachment 5 have also been updated and i | Type: Special Notice | Sol#: FDABAA-25-00123